Oncology & Hematology Coding Alert
Target Q9981 for Rolapitant
Question: How can we code for rolapitant? Was there a recent update on coding for this drug?
Georgia Subscriber
Answer: Medicare has added HCPCS code Q9981 (Rolapitant, oral, 1 mg) for “the hospital outpatient setting, where there have not previously been specific codes available.” This update is a recent one and was published in the MLN Matters release on June 28, 2016.
What is rolapitant? Rolapitant is the generic form of the drug, Varubi, and helps to alleviate nausea and vomiting after emetogenic cancer chemotherapy.
Resource: For a closer look at the HCPCS additions and changes, visit https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9658.pdf.
Oncology & Hematology Coding Alert
- HCPCS Update:
Not Coding For Daratumumab Yet? Update Your HCPCS Code List
You can only claim for combination therapy with daratumumab. Breaking news: daratumumab has received U.S. [...] - ICD-10-CM Update:
Narrow Down To K13.3 For Hairy Leukoplakia
You can’t think leukoplakia for K13.3; don’t forget additional codes that apply. You may commonly [...] - Quick Review of Hairy Leukoplakia Basics
Here are some basic features of hairy leukoplakia that you can bank upon when reading [...] - E/M Guide:
Find Answers For Your Key E/M Challenges And Keep Your Payment Flowing In
Tip: Check the three-year rule for established patients. Your practice probably reports E/M codes more [...] - You Be the Coder:
Target Q9981 for Rolapitant
Question: How can we code for rolapitant? Was there a recent update on coding for this [...] - Reader Question:
Check Laterality for Hearing Loss
Question: Our physician documented a diagnosis of mixed hearing loss in a patient who was [...] - Reader Question:
Check E/M components for New vs Established Patients
Question: We are reporting an E/M encounter for a follow-up patient when our provider did not [...]
